Ashley Dalton MP: speeches

Speeches

• 21 Oct 2025 · Cancer Diagnoses · Hansard source

  More

  I thank the hon. Gentleman for his question, but I think he might be mistaken. We are opening more CDCs than ever before—I have lost count of the amount of CDCs we have been invited to open—and we are making sure that people have access to diagnostics in their community, from hospital to community, with the most access that there has been for some years.

• 21 Oct 2025 · Cancer Diagnoses · Hansard source

  More

  I thank my hon. Friend for her question and her well wishes. We are taking cancer detection seriously in general practice, and there is work to do. It is why we have recently launched Jess’s rule, which is a patient safety initiative that means when patients return three times with worsening or undiagnosed symptoms, GPs must reflect, review and rethink. That could include a second opinion, episodic continuity of care or ordering additional tests. I wish her constituent the very best and offer her my sympathies in her diagnosis.

• 21 Oct 2025 · Vaccine Damage Payment Scheme · Hansard source

  More

  I reiterate my deepest sympathies to all those who have experienced harm following vaccination and to their families. I recognise many of the concerns that campaigners have raised regarding the vaccine damage payment scheme. Their input will shape our ongoing consideration of reforms to the scheme and I will keep Parliament updated as appropriate.

• 21 Oct 2025 · Vaccine Damage Payment Scheme · Hansard source

  More

  The vaccine damage payment scheme is not a compensation scheme but a one-off payment. It is important to state that. As I have said, we recognise that there are concerns, which campaigners have raised, and their input is shaping our ongoing consideration of reforms to the scheme. All vaccines in the UK are authorised by the Medicines and Healthcare products Regulatory Agency, which is an independent body recognised globally for its high safety standards. This Labour Government base our decisions on scientific fact, unlike Reform, which has still not apologised for platforming dangerous anti-vax conspiracy theories. I can only assume that it is less interested in protecting people than it is in alarming folk for political advantage.

• 14 Oct 2025 · Postural Tachycardia Syndrome · Hansard source

  More

  I thank my hon. Friend for her intervention. As we know, guidelines are only as strong as the evidence and research that they are based on. We need systematic, robust data to determine which treatments and interventions are most effective. While we are backing our life sciences sector to come up with tomorrow’s treatments for long-term conditions, we are also directly funding research through the National Institute for Health and Care Research. The NIHR is currently backing a study, known as the LOCOMOTION study, with more than £3 million to examine the connection between long covid and autonomic nervous system disorders, especially PoTS. The NIHR funds research proposals through open competition, based on their scientific quality, value for money and impact on patients. The NIHR welcomes research proposals, and I appeal to any researchers to apply with proposals for PoTS-related research that this Government could fund. We want to see proposals and fund those that can be brought forward. Those researchers’ work could be life-changing for thousands of people across our country. Locally developed care pathways are clearly important for supporting people with PoTS, because they help to address the condition’s unique challenges.

• 14 Oct 2025 · Postural Tachycardia Syndrome · Hansard source

  More

  The hon. Member pre-empts the end of my speech, where I was going to say that I would be more than happy to meet specialists in this area to discuss how we can move forward. It is important that today’s debate is the beginning of our conversation, not the end of it. The Government are focused on standardising and co-ordinating care across different settings so that local pathways can address systemic challenges, especially the inconsistent referrals that many people with PoTS face, as has been raised today.

• 14 Oct 2025 · Postural Tachycardia Syndrome · Hansard source

  More

  It is a pleasure, as always, to serve under your chairmanship, Sir Desmond. I congratulate my hon. Friend the Member for Lancaster and Wyre (Cat Smith) for bringing forward this important issue. This place is vastly enriched by our experiences, and it is nothing short of inspiring how my hon. Friend’s diagnosis has led her to become a passionate advocate for the PoTS community, raising awareness and holding the Government to account. I thank her for sharing her story and Elise’s case with me. I assure my hon. Friend and Elise that tackling health inequalities is my No. 1 priority as the Minister for Public Health and Prevention. I also thank many hon. Members for their interventions and for sharing their constituents’ stories. Given this short debate, there is not time to respond to each intervention—I will not even attempt to do so—but I assure hon. Members that their points have been noted and that their presence today is testament to the importance of the issue for hon. Members on both sides of the House. I recognise that people with PoTS wake up and confront every day through sheer willpower, and that showering, cooking and walking to the corner shop each become small expeditions that need endless rest and planning. We are determined to help improve their lives. Postural tachycardia syndrome, more commonly known as PoTS, is not a rare condition. It affects around 120,000 people in the UK. It is a debilitating, multi-system disorder that can significantly impact someone’s quality of life. As my hon. Friend the Member for Lancaster and Wyre points out, the path to a PoTS diagnosis is often a long and arduous one, filled with frustration and misdiagnosis as patients fight to be heard. Even after a diagnosis is made, patients may struggle to access the services that they need due to a lack of specialist care and limited understanding among health professionals. That results in long delays in treatment, often leaving those affected unable to work or live their lives. I turn to the specific issues raised by my hon. Friend, starting with guidance. For too long, patients have faced systemic barriers to care and an unacceptable postcode lottery for support. It cannot be right that in modern Britain, where someone happens to be born determines the care that they receive. She rightly points out that that inequality is rooted in the lack of clear national guidance for healthcare professionals. Without guidance from bodies such as NICE, clinicians often lack the confidence and know-how to identify and manage this complex condition effectively. There are some reasons for the difficulty in providing such guidance, including the amount of available evidence, the fact that PoTS is often managed with lifestyle changes, and the overlap with other conditions such as long covid and myalgic encephalomyelitis/chronic fatigue syndrome, which can bring similar debilitating symptoms. All those issues can make the development of clearcut guidelines challenging. However, in its clinical knowledge summary on blackouts and syncope, NICE sets out in black and white a clear definition of PoTS with the right tests to diagnose it, and symptom-based management. NICE has also published guidance that mentions PoTS in relation to other conditions, such as its guideline on ME/CFS, which acknowledges the overlap between these syndromes. Several other organisations, including PoTS UK and the international Heart Rhythm Society, provide information too. Services for long-term conditions such as PoTS are commissioned locally through integrated care boards. That approach gives local clinicians the flexibility that they need to tailor services to the specific needs of their communities. Providing a PoTS specialist service is a fundamental part of the ICBs’ statutory role in planning and delivering health to the people they serve, and when an ICB fails to meet its statutory functions, NHS England has a range of proportionate enforcement powers. Let me be clear: we expect NHS England to hold ICBs to account by demanding that they provide clear assurance on how they are meeting their responsibilities, and where they are failing people with PoTS—let me say this very clearly, publicly, now—we expect them to rectify it.

• 14 Oct 2025 · Postural Tachycardia Syndrome · Hansard source

  More

  As the hon. Member is probably aware, the Government are working hard to develop policies to support people, particularly people with health conditions, into work. These issues are being raised through the “Get Britain Working” plan, which my right hon. and hon. Friends in the Department for Work and Pensions are bringing forward. Working to support people with any long-term health condition, including PoTS, is a crucial part of the Government’s effort to improve the economy and get Britain working. The hon. Member’s comments are noted. We are determined to improve patient outcomes and ensure more tailored and efficient care that acknowledges the complexity of PoTS, beyond just a single specialty. The Government’s 10-year plan for health not only deals with prevention, but offers potential for people with PoTS through the increased focus on community-based rather than hospital care, through the better integration of services, and through our analogue to digital shift and improvement of digital tools. Given that PoTS is frequently co-morbid with ME/CFS, the final delivery plan for ME/CFS, which the Government published this summer, will have a positive impact for many PoTS patients too. I again thank my hon. Friend the Member for Lancaster and Wyre for securing the debate. As I said, I hope that this is the beginning of our conversation, and that we can continue to discuss how we can ensure we are delivering for people with PoTS as we work towards building an NHS that is fit for the future. Question put and agreed to.

• 2 Sept 2025 · Defibrillators · Hansard source

  More

  It is a pleasure to serve under your chairship, Mr Stringer. I thank all hon. Members who have contributed to the debate. It has been really well attended, with over 20 Back-Bench contributions. I also thank the Front-Bench spokespeople for their contributions. I will try to respond to all the issues raised, but there have been a tremendous number, so if I cannot respond to them all, I will write to hon. Members on any that I do not cover. I recognise the individuals who have been honoured by hon. Members, particularly Tom Sharples, Naomi Rees-Issitt, Dylan Rich and his family, and Andrew and Jeanette, all of whom have been appropriately recognised. I also particularly thank my hon. Friend the Member for Bishop Auckland (Sam Rushworth) for securing the debate. I was sorry to hear how his mum needed emergency resuscitation when he was a child, and I offer my deepest sympathies on the death of his friend and colleague, George Smith. A cardiac arrest can be an incredibly frightening experience for a person and their loved ones. My hon. Friend knows that rapid access to defibrillators can be the difference between life and death. As he said, early defibrillation within three to five minutes of collapse can increase a person’s chances of survival by as much as 50% to 70%. Thanks to data collected by the British Heart Foundation, we know that AEDs are only used around one in 10 times where they could have saved a life. I am pleased to update the House on what the Government are doing to drive that figure upwards. Our 10-year plan for health is shifting the focus of our NHS from hospitals to community. It is right that local communities are leading the way through public bodies, businesses and charities. I commend the hard work of London Hearts, AED Donate and the Community Heartbeat Trust and other organisations raised today. Forgive me if I miss some of them: Hearts for Herts, Lucky2Bhere, Stargate & Crookhill Community Centre, Lechlade Lions, Friends of Frome Hospital, the Daniel Berg Foundation, Southport Saviours, the Paul Alan Project, Evanton Residents’ Association and Lauren’s campaign. There are many more organisations and projects working hard to improve access to AEDs for all. There are now more than 110,000 AEDs across the UK registered on the Circuit, the independent AED database backed by the NHS. The Circuit continues to see a regular increase in the number of defibs registered. I was delighted to hear hon. Members talk about encouraging defib guardians in their areas to register. More than 30,000 have been added in the past two years alone and we look forward to more. As my hon. Friend the Member for Bishop Auckland highlighted, more than 3,000 were provided by the Department of Health and Social Care’s community defibrillator fund. My hon. Friend also rightly pointed out gaps in provision across the UK. As someone who represents a rural constituency, I completely understand his position and that of hon. Members from other rural communities, many of whom spoke in today’s debate. That is why we have partnered with Smarter Society, which has helped us get AEDs to communities with the greatest need where they have the greatest impact. That includes remote communities with extended ambulance response times, places with high footfall and hotspots for cardiac arrests, such as sporting arenas, venues for vulnerable people and deprived areas. We fully funded the first 100 devices distributed by the Smarter Society, and have committed to supporting communities by matching the funds they spend on defibrillators pound for pound. Local communities will determine where defibs are kept for the best response to the needs of their communities. Unfortunately, defibs sometimes get stolen and communities are best placed to decide whether they should be in locked cabinets. Some charities, such as the British Heart Foundation, insist that devices they provide are kept unlocked. My hon. Friend the Member for West Dunbartonshire (Douglas McAllister) made the interesting suggestion that the theft or damage of a defib should be a specified offence, which I will raise with relevant Ministers. If the defibrillator is registered on the Circuit, the national AED network, the guardian will receive regular reminders to record checks on the AED. To support maintenance, the Circuit sends guardians notifications and records when an AED is used, so as to notify the guardian that pads will need to be replaced. Many hon. Members referred to training. AEDs are designed to be simple yet lifesaving devices that anyone can use without formal training. That said, training can help people use defibrillators with greater confidence. The NHS runs training sessions on first aid, CPR and the use of defibrillators in communities and schools, to support Resuscitation Council UK’s “Restart a Heart” initiative. The NHS England has trained more than 35,800 adults and children in CPR and defibrillation in the past 13 years, and more than 2,100 people since January 2025. NHS England also runs workshops in harder-to-reach communities and ethnically diverse groups, training more than 400 people this year. I was interested to hear the shadow Minister’s comments about women, and some people’s reluctance to use defibs. I will speak to the Minister responsible for women’s health about how that can be improved. Many Members raised ambulance response times, which the Government are determined to improve so that people can be reassured that help is on the way. Our urgent and emergency care plan commits to reducing ambulance response times for category 2 incidents to 30 minutes on average this year. We are tackling unacceptable handover delays by introducing a maximum 45-minute standard, ensuring that ambulances are released more quickly and get back on the road to treat patients. I am pleased that in the region of my hon. Friend the Member for Bishop Auckland the latest figures show that average response times for category 1—the most serious, life-threatening cases—were six minutes and 13 seconds, which is faster than the national standard of seven minutes. The hard work of paramedics, clinicians and NHS staff makes that possible, and I commend them for that. We will continue to do all we can from Government to support those improvements and reduce variation in response times across the country. Many hon. Members who spoke today raised the issue of VAT on devices and parts. I do not want the provision of defibrillators in communities to be a matter of cost—I will discuss that with Treasury colleagues. Decisions on VAT are a matter for my right hon. Friend the Chancellor. I will make sure that Treasury colleagues are aware of the issues raised in this debate today. The Government will continue to keep the matter under review. My hon. Friend the Member for Bishop Auckland spoke powerfully about the prevention issues. Anyone who has read our 10-year plan for the NHS will know that he is pushing at an open door on that with this Government, because our ambition to cut premature mortality from heart disease and stroke by a quarter within a decade is a key tenet of our 10-year plan. We are making that shift from treatment to prevention. While we are tough on treating cardiac arrest, we will act on what public health doctors call the “causes of the causes”, with action on smoking, obesity, high cholesterol, high blood pressure, and access to green spaces for exercise. This year we have set targets for integrated care boards to increase the percentage of patients with GP-recorded CVD who have their cholesterol levels managed to safer levels. Almost nine in 10 people with GP-recorded hypertension in England had their blood pressure checked in the last year, and more than two thirds had their blood pressure treated to target in the last year. The NHS health check programme engages over 1.4 million people and, through behavioural and clinical interventions, prevents around 500 heart attacks or strokes a year. We are also making the shift from analogue to digital. To improve the programme’s uptake and engagement we are developing the NHS health check online, which will be available through the NHS app. The Opposition’s shadow Minister, the hon. Member for Sleaford and North Hykeham (Dr Johnson), spoke about the national curriculum review. I will ensure that the issues are raised with my colleagues in the Department for Education. I was very interested to hear the ideas and thoughts of the Liberal Democrat spokesperson, the hon. Member for Chichester (Jess Brown-Fuller), on innovation; I commit to exploring that further. I once again thank my hon. Friend the Member for Bishop Auckland for securing this important debate. I look forward to working with him long into the future to get stuff done. I hope we have shown that the Government are committed to shifting the focus from hospital to community, moving care closer to people through community-based initiatives and targets, and embracing the digital transformation of the NHS. Together those shifts will mean healthier communities, more lives saved and an NHS fit for the future.

• 22 Jul 2025 · Metachromatic Leukodystrophy Screening · Hansard source

  More

  I thank my hon. Friend for raising this matter. Lily’s story really lays bare the heartbreak that rare diseases can bring and the vital role that early diagnosis can play. I am happy to meet my hon. Friend and Lily’s family. May I suggest that we meet when the UK National Screening Committee has completed its review, so that the Government have received advice on this important matter? We can then discuss that advice together.

• 22 Jul 2025 · Metachromatic Leukodystrophy Screening · Hansard source

  More

  I thank my hon. Friend for raising this issue and congratulate his constituent David Kiddie on the 190-mile walk he completed earlier this year to raise awareness and funds for those with MLD and their families. The Government are committed to listening to those with MLD and their families and acting with compassion and care to support them. The UK National Screening Committee, which advises the Government on all screening matters, is consulting on the outcomes of an evidence review looking at whether to screen for MLD.

• 22 Jul 2025 · Metachromatic Leukodystrophy Screening · Hansard source

  More

  As the hon. Lady points out, for Teddy and Lily it is sadly too late for that treatment. That is why we are looking at screening. I would be delighted to meet with Teddy’s family once we have the outcome from the screening review.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  We are already delivering. As I have said, the Tobacco and Vapes Bill is making its way through Parliament at the moment. We are tackling the obesity crisis through tackling junk food advertising to children. We are working on school food standards, and we are also bringing in rules around planning for junk food establishments near schools. We are supporting people to make healthier choices when it comes to alcohol, and we are tackling air pollution, which particularly affects working-class communities. The list goes on and on, and I would be more than happy to give the hon. Member another list if he needs one.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  There is nothing covert about the decisions on the Fleming Fund. It has been perfectly open and clear that the existing funding has been cut. Having said that, the work and partnerships that have been developed on AMR continue. The UK continues to be a global leader on this issue, and our ambassador, Dame Sally, continues to do sterling work on it.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  The 10-year health plan sets out how we are transforming our approach to preventing ill health through a set of ambitious measures that make the healthy choice the easy choice. Among those measures is our mandatory partnership with food businesses, through which we will make shopping baskets across the country healthier, and our landmark Tobacco and Vapes Bill, to help deliver our ambition for a smoke-free UK by gradually ending the sale of tobacco products across the country.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  I thank my hon. Friend for her question and commend the work she has done on this issue and her wonderful contribution to the Westminster Hall debate that I responded to recently. It is a really important issue and something we are keen to explore further. The Secretary of State and I would be delighted to meet with her and other campaigners.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  The Government are committed to addressing health inequalities experienced by people living with rare conditions such as sickle cell disorder. Pioneering research is a cross-cutting theme of the UK rare diseases framework, but we know that there are a small number of rare conditions with a large amount of research, while many more have little or no funded research. I want to confirm for my hon. Friend that the National Institute for Health and Care Research welcomes funding applications for research into all and any aspects of health or care, including sickle cell disorder.

• 22 Jul 2025 · 10-Year Health Plan: Prevention of Ill Health · Hansard source

  More

  We are already delivering. The hon. Lady is absolutely right to identify that a number of plans are being brought forward. We take this matter very seriously, and we want to ensure that we get it right. We plan: we plan so that we perform effectively, and we plan for success. The national cancer plan will be coming later this year, and I am sure that we will be able to outline a timetable for all other plans. I assure her that planning is not doing nothing; planning is making sure that we get this right and that we deliver.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  NHS England has worked with key stakeholders to develop a framework to aid integrated care systems to commission high-quality services for children and young people with cerebral palsy, including as they transition to adult services. Guidance from the National Institute for Health and Care Excellence on cerebral palsy in the under-25s also sets out key considerations in transition planning.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  I thank the hon. Member for raising this issue. That is not what I was expecting. A written ministerial statement has been tabled, and I will speak to officials and make sure that that plan is available as it should be.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  We are looking very carefully at the arguments for national screening. The hon. Member will be aware that there are concerns. We have to look at this very carefully to ensure that screening programmes do not cause unnecessary harm, but targeted and widespread screening for prostate cancer is something that the Department is looking at and will report on in due course.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  Parkrun is a fantastic organisation that is doing amazing work. We know that movement saves the NHS around £10.5 billion a year, but 12 million adults are still inactive, and we need a team effort to succeed in getting millions more moving. There is a lot we can learn from Parkrun, and I would happily consider any invitation to meet it.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  The national cancer plan, which will be introduced towards the end of this year, will cover cancer facilities across England. I would be more than happy to meet my hon. Friend to discuss the particulars in her constituency.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  The cancer plan will reflect the three shifts in the 10-year plan, including from hospital to community. Macmillan, Cancer Research UK and Cancer52 all sit on the steering board for the cancer plan, and I meet them regularly. Last week, we announced the Diagnostic Connect partnership with the third sector, linking patients with third sector services on diagnosis. The cancer plan will cover this for the whole of England and build on the commitments in the 10-year plan.

• 22 Jul 2025 · Topical Questions · Hansard source

  More

  The national cancer plan for England will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and aftercare, as well as prevention and innovation. It will seek to improve every aspect of cancer care, including establishing targets for delivery right through the cancer pathway.